CN Stock MarketDetailed Quotes

Jafron Biomedical (300529)

Watchlist
  • 19.23
  • -0.22-1.13%
Market Closed May 15 15:00 CST
15.36BMarket Cap27.20P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Jafron Biomedical (300529) Income Statement

All
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q9)Sep 30, 2025
(Q6)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
Total operating revenue
2.33%560.62M
-24.86%2.01B
-29.13%1.56B
-24.15%1.13B
-26.40%547.84M
39.27%2.68B
47.76%2.2B
47.77%1.5B
30.00%744.34M
-22.84%1.92B
Operating revenue
2.33%560.62M
-24.86%2.01B
-29.13%1.56B
-24.15%1.13B
-26.40%547.84M
39.27%2.68B
47.76%2.2B
47.77%1.5B
30.00%744.34M
-22.84%1.92B
Other operating revenue
----
-35.81%4.7M
----
-66.89%1.5M
----
114.26%7.33M
----
222.73%4.53M
----
-24.74%3.42M
Total operating cost
-7.02%307.8M
-21.79%1.34B
-20.42%1.02B
-19.73%691.48M
-21.54%331.03M
20.47%1.71B
26.44%1.28B
22.05%861.39M
20.39%421.94M
-8.35%1.42B
Operating cost
20.85%127.54M
-16.73%428.5M
-22.61%317.57M
-21.37%228.89M
-33.48%105.54M
32.13%514.61M
42.80%410.33M
47.87%291.11M
41.52%158.66M
-11.51%389.46M
Operating tax surcharges
20.53%11.06M
-14.58%36.79M
-21.31%27.59M
-17.33%19.82M
-21.36%9.17M
35.38%43.07M
49.75%35.05M
52.64%23.97M
37.04%11.67M
-9.28%31.82M
Operating expense
-26.19%84.09M
-27.53%501.49M
-24.98%382.81M
-26.75%249.61M
-28.12%113.93M
13.35%691.99M
15.69%510.26M
5.31%340.76M
1.00%158.5M
-12.86%610.5M
Administration expense
-18.56%31.33M
-30.41%131.66M
-10.98%114.57M
-10.99%75.36M
-0.02%38.46M
6.66%189.2M
14.25%128.71M
16.13%84.67M
39.32%38.47M
28.40%177.39M
Financial expense
-26.06%8.1M
28.36%41.64M
33.65%30.74M
151.30%20.35M
2,198.73%10.95M
195.72%32.44M
185.67%23M
145.20%8.1M
105.47%476.36K
-90.21%-33.9M
-Interest expense (Financial expense)
-13.23%12.35M
-16.01%53.51M
-16.09%40.23M
-17.62%26.82M
-12.93%14.24M
17.26%63.71M
19.00%47.95M
29.07%32.56M
33.49%16.35M
50.74%54.33M
-Interest Income (Financial expense)
-65.75%-5.44M
53.31%-14.47M
59.80%-10.51M
71.53%-6.99M
79.04%-3.28M
64.76%-31M
60.99%-26.13M
43.46%-24.54M
27.08%-15.65M
-65.15%-87.96M
Research and development
-13.76%45.69M
-17.35%198.45M
-15.85%147.03M
-13.59%97.46M
-2.20%52.98M
-2.15%240.09M
-0.93%174.72M
-1.60%112.79M
0.27%54.17M
-3.36%245.38M
Credit Impairment Loss
-477.54%-1.61M
296.29%3.38M
136.12%3.15M
131.40%2.49M
133.49%427.28K
-120.92%-1.72M
-456.34%-8.73M
-299.36%-7.91M
-264.19%-1.28M
320.33%8.23M
Asset Impairment Loss
-1,904.42%-7.13M
-489.08%-63.88M
-53,822.38%-8.26M
---6.25M
--395.25K
61.52%-10.84M
---15.32K
--0
--0
-332.78%-28.18M
Other net revenue
-57.40%8.39M
-77.97%17.5M
-28.38%50.67M
-10.56%38.24M
-25.13%19.7M
88.67%79.46M
64.05%70.74M
29.01%42.75M
53.85%26.32M
-52.18%42.11M
Fair value change income
-25.96%9.49M
-98.92%11.07K
9,137.44%30.92M
271.41%21.55M
1,163.21%12.82M
--1.02M
--334.75K
--5.8M
--1.01M
----
Invest income
32.89%823.04K
27.05%53.48M
-64.57%8.75M
1.85%8.33M
-75.50%619.35K
--42.09M
--24.69M
--8.18M
--2.53M
----
Asset deal income
97.73%-47.5K
-102.19%-79.85K
-219.83%-2.84M
-165.33%-1.41M
-264.10%-2.1M
-45.83%3.64M
-59.89%2.37M
-64.28%2.16M
-76.75%1.28M
677.04%6.72M
Other revenue
-8.87%6.87M
-45.68%24.59M
-63.61%18.95M
-60.81%13.53M
-66.88%7.54M
-18.21%45.27M
49.84%52.08M
49.37%34.52M
110.20%22.78M
-31.87%55.35M
Operating profit
10.45%261.22M
-33.92%690.79M
-40.43%586.38M
-28.92%481.17M
-32.18%236.51M
92.23%1.05B
91.09%984.36M
99.39%676.98M
45.80%348.72M
-47.17%543.82M
Add:Non operating Income
-80.01%4.56K
7,395.17%15.52M
682.92%838.45K
82.14%181.15K
-63.29%22.83K
-35.75%207.09K
-66.49%107.09K
-59.57%99.45K
-62.65%62.17K
-13.26%322.34K
Less:Non operating expense
-89.42%1.21M
19.61%46.18M
17.81%35.17M
15.56%19.45M
28.88%11.4M
66.98%38.61M
80.25%29.85M
57.22%16.83M
15.36%8.84M
77.61%23.12M
Total profit
15.50%260.01M
-34.44%660.13M
-42.17%552.05M
-30.04%461.9M
-33.77%225.13M
93.27%1.01B
91.35%954.62M
100.65%660.25M
46.73%339.93M
-48.76%521.02M
Less:Income tax cost
6.53%39.37M
-33.37%128.46M
-39.57%100.2M
-33.12%73.24M
-34.02%36.95M
102.29%192.78M
111.33%165.79M
103.29%109.5M
53.74%56.01M
-29.86%95.3M
Net profit
17.26%220.65M
-34.70%531.67M
-42.72%451.86M
-29.43%388.67M
-33.72%188.18M
91.25%814.19M
87.62%788.83M
100.13%550.76M
45.42%283.93M
-51.67%425.72M
Net profit from continuing operation
17.26%220.65M
-34.70%531.67M
-42.72%451.86M
-29.43%388.67M
-33.72%188.18M
91.25%814.19M
87.62%788.83M
100.13%550.76M
45.42%283.93M
-51.67%425.72M
Less:Minority Profit
122.24%134.87K
80.86%-1.15M
51.13%-1.37M
39.77%-1.05M
27.65%-606.29K
44.20%-6.01M
12.79%-2.81M
24.08%-1.75M
34.49%-837.96K
-24.94%-10.77M
Net profit of parent company owners
16.81%220.51M
-35.04%532.82M
-42.75%453.23M
-29.46%389.72M
-33.71%188.78M
87.91%820.2M
86.86%791.63M
99.10%552.51M
44.90%284.77M
-50.93%436.49M
Earning per share
Basic earning per share
21.74%0.28
-34.29%0.69
-40.40%0.59
-26.09%0.51
-34.51%0.23
90.91%1.05
86.79%0.99
97.14%0.69
42.76%0.3512
-50.89%0.55
Diluted earning per share
21.74%0.28
-35.51%0.69
-41.24%0.57
-27.94%0.49
-34.19%0.23
87.72%1.07
86.54%0.97
100.00%0.68
44.00%0.3495
-49.56%0.57
Other composite income
165.46%2.8M
-96.08%1.05M
181.20%26.93M
Other composite income of parent company owners
----
165.46%2.8M
----
----
----
-96.08%1.05M
----
----
----
181.20%26.93M
Total composite income
17.26%220.65M
-34.44%534.47M
-42.72%451.86M
-29.43%388.67M
-33.72%188.18M
80.10%815.24M
87.62%788.83M
100.13%550.76M
45.42%283.93M
-46.61%452.65M
Total composite income of parent company owners
16.81%220.51M
-34.78%535.62M
-42.75%453.23M
-29.46%389.72M
-33.71%188.78M
77.21%821.25M
86.86%791.63M
99.10%552.51M
44.90%284.77M
-45.89%463.42M
Total composite income of minority owners
122.24%134.87K
80.86%-1.15M
51.13%-1.37M
39.77%-1.05M
27.65%-606.29K
44.20%-6.01M
12.79%-2.81M
24.08%-1.75M
34.49%-837.96K
-24.94%-10.77M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
PwC China (Special General Partnership)
--
--
--
PwC China (Special General Partnership)
--
--
--
PwC China (Special General Partnership)
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q9)Sep 30, 2025(Q6)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023
Total operating revenue 2.33%560.62M-24.86%2.01B-29.13%1.56B-24.15%1.13B-26.40%547.84M39.27%2.68B47.76%2.2B47.77%1.5B30.00%744.34M-22.84%1.92B
Operating revenue 2.33%560.62M-24.86%2.01B-29.13%1.56B-24.15%1.13B-26.40%547.84M39.27%2.68B47.76%2.2B47.77%1.5B30.00%744.34M-22.84%1.92B
Other operating revenue -----35.81%4.7M-----66.89%1.5M----114.26%7.33M----222.73%4.53M-----24.74%3.42M
Total operating cost -7.02%307.8M-21.79%1.34B-20.42%1.02B-19.73%691.48M-21.54%331.03M20.47%1.71B26.44%1.28B22.05%861.39M20.39%421.94M-8.35%1.42B
Operating cost 20.85%127.54M-16.73%428.5M-22.61%317.57M-21.37%228.89M-33.48%105.54M32.13%514.61M42.80%410.33M47.87%291.11M41.52%158.66M-11.51%389.46M
Operating tax surcharges 20.53%11.06M-14.58%36.79M-21.31%27.59M-17.33%19.82M-21.36%9.17M35.38%43.07M49.75%35.05M52.64%23.97M37.04%11.67M-9.28%31.82M
Operating expense -26.19%84.09M-27.53%501.49M-24.98%382.81M-26.75%249.61M-28.12%113.93M13.35%691.99M15.69%510.26M5.31%340.76M1.00%158.5M-12.86%610.5M
Administration expense -18.56%31.33M-30.41%131.66M-10.98%114.57M-10.99%75.36M-0.02%38.46M6.66%189.2M14.25%128.71M16.13%84.67M39.32%38.47M28.40%177.39M
Financial expense -26.06%8.1M28.36%41.64M33.65%30.74M151.30%20.35M2,198.73%10.95M195.72%32.44M185.67%23M145.20%8.1M105.47%476.36K-90.21%-33.9M
-Interest expense (Financial expense) -13.23%12.35M-16.01%53.51M-16.09%40.23M-17.62%26.82M-12.93%14.24M17.26%63.71M19.00%47.95M29.07%32.56M33.49%16.35M50.74%54.33M
-Interest Income (Financial expense) -65.75%-5.44M53.31%-14.47M59.80%-10.51M71.53%-6.99M79.04%-3.28M64.76%-31M60.99%-26.13M43.46%-24.54M27.08%-15.65M-65.15%-87.96M
Research and development -13.76%45.69M-17.35%198.45M-15.85%147.03M-13.59%97.46M-2.20%52.98M-2.15%240.09M-0.93%174.72M-1.60%112.79M0.27%54.17M-3.36%245.38M
Credit Impairment Loss -477.54%-1.61M296.29%3.38M136.12%3.15M131.40%2.49M133.49%427.28K-120.92%-1.72M-456.34%-8.73M-299.36%-7.91M-264.19%-1.28M320.33%8.23M
Asset Impairment Loss -1,904.42%-7.13M-489.08%-63.88M-53,822.38%-8.26M---6.25M--395.25K61.52%-10.84M---15.32K--0--0-332.78%-28.18M
Other net revenue -57.40%8.39M-77.97%17.5M-28.38%50.67M-10.56%38.24M-25.13%19.7M88.67%79.46M64.05%70.74M29.01%42.75M53.85%26.32M-52.18%42.11M
Fair value change income -25.96%9.49M-98.92%11.07K9,137.44%30.92M271.41%21.55M1,163.21%12.82M--1.02M--334.75K--5.8M--1.01M----
Invest income 32.89%823.04K27.05%53.48M-64.57%8.75M1.85%8.33M-75.50%619.35K--42.09M--24.69M--8.18M--2.53M----
Asset deal income 97.73%-47.5K-102.19%-79.85K-219.83%-2.84M-165.33%-1.41M-264.10%-2.1M-45.83%3.64M-59.89%2.37M-64.28%2.16M-76.75%1.28M677.04%6.72M
Other revenue -8.87%6.87M-45.68%24.59M-63.61%18.95M-60.81%13.53M-66.88%7.54M-18.21%45.27M49.84%52.08M49.37%34.52M110.20%22.78M-31.87%55.35M
Operating profit 10.45%261.22M-33.92%690.79M-40.43%586.38M-28.92%481.17M-32.18%236.51M92.23%1.05B91.09%984.36M99.39%676.98M45.80%348.72M-47.17%543.82M
Add:Non operating Income -80.01%4.56K7,395.17%15.52M682.92%838.45K82.14%181.15K-63.29%22.83K-35.75%207.09K-66.49%107.09K-59.57%99.45K-62.65%62.17K-13.26%322.34K
Less:Non operating expense -89.42%1.21M19.61%46.18M17.81%35.17M15.56%19.45M28.88%11.4M66.98%38.61M80.25%29.85M57.22%16.83M15.36%8.84M77.61%23.12M
Total profit 15.50%260.01M-34.44%660.13M-42.17%552.05M-30.04%461.9M-33.77%225.13M93.27%1.01B91.35%954.62M100.65%660.25M46.73%339.93M-48.76%521.02M
Less:Income tax cost 6.53%39.37M-33.37%128.46M-39.57%100.2M-33.12%73.24M-34.02%36.95M102.29%192.78M111.33%165.79M103.29%109.5M53.74%56.01M-29.86%95.3M
Net profit 17.26%220.65M-34.70%531.67M-42.72%451.86M-29.43%388.67M-33.72%188.18M91.25%814.19M87.62%788.83M100.13%550.76M45.42%283.93M-51.67%425.72M
Net profit from continuing operation 17.26%220.65M-34.70%531.67M-42.72%451.86M-29.43%388.67M-33.72%188.18M91.25%814.19M87.62%788.83M100.13%550.76M45.42%283.93M-51.67%425.72M
Less:Minority Profit 122.24%134.87K80.86%-1.15M51.13%-1.37M39.77%-1.05M27.65%-606.29K44.20%-6.01M12.79%-2.81M24.08%-1.75M34.49%-837.96K-24.94%-10.77M
Net profit of parent company owners 16.81%220.51M-35.04%532.82M-42.75%453.23M-29.46%389.72M-33.71%188.78M87.91%820.2M86.86%791.63M99.10%552.51M44.90%284.77M-50.93%436.49M
Earning per share
Basic earning per share 21.74%0.28-34.29%0.69-40.40%0.59-26.09%0.51-34.51%0.2390.91%1.0586.79%0.9997.14%0.6942.76%0.3512-50.89%0.55
Diluted earning per share 21.74%0.28-35.51%0.69-41.24%0.57-27.94%0.49-34.19%0.2387.72%1.0786.54%0.97100.00%0.6844.00%0.3495-49.56%0.57
Other composite income 165.46%2.8M-96.08%1.05M181.20%26.93M
Other composite income of parent company owners ----165.46%2.8M-------------96.08%1.05M------------181.20%26.93M
Total composite income 17.26%220.65M-34.44%534.47M-42.72%451.86M-29.43%388.67M-33.72%188.18M80.10%815.24M87.62%788.83M100.13%550.76M45.42%283.93M-46.61%452.65M
Total composite income of parent company owners 16.81%220.51M-34.78%535.62M-42.75%453.23M-29.46%389.72M-33.71%188.78M77.21%821.25M86.86%791.63M99.10%552.51M44.90%284.77M-45.89%463.42M
Total composite income of minority owners 122.24%134.87K80.86%-1.15M51.13%-1.37M39.77%-1.05M27.65%-606.29K44.20%-6.01M12.79%-2.81M24.08%-1.75M34.49%-837.96K-24.94%-10.77M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --PwC China (Special General Partnership)------PwC China (Special General Partnership)------PwC China (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Petroleum
No. Symbol 20D % Chg
Sample Name
Sample Code
 +2.64%
Sample Name
Sample Code
 -0.13%
Sample Name
Sample Code
 -1.05%
4
SHANGHAI PECHEM
00338
-1.56%
5
SINOPEC CORP
00386
-2.39%
View More
No. Symbol 20D % Chg
Sample Name
Sample Code
 +41.26%
Sample Name
Sample Code
 +31.66%
Sample Name
Sample Code
 +26.25%
4
Digital China Group
000034
+15.29%
5
Loongson Technology Corporation
688047
+12.74%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -